Quick facts about pneumonia
- Globally, pneumonia is the leading cause of death among children under five after the neonatal period.
- Each year, pneumonia kills more children than AIDS, malaria and measles combined. More than 2 million children die from pneumonia annually, accounting for almost a fifth of deaths among children under five across the world.
- Pneumonia is a preventable and treatable disease that affects children and families everywhere, but mostly in South Asia and sub-Saharan Africa,
- Most healthy children are able to fight the disease, but for those with fragile immune systems – due to malnutrition, undernourishment or other diseases – it can be deadly.
- Pneumonia is a severe form of acute respiratory infection, mainly caused by a bacterial pathogen. With early diagnosis and care, the infection can be easily treated with antibiotics.
Quick facts about tuberculosis
- According to the World Health Organization, one third of the world’s population is infected with TB.
- In 2012, 9 million people fell ill due to TB, and there were 1.3 million TB deaths. In that same year, national notification systems missed about 3 million people who developed TB.
- Today, TB remains the leading cause of death for people living with HIV.
Our TB and pneumonia programs focus on behavior change communication to encourage care-seeking behavior, strengthen capacity of public and private providers to diagnose either disease and support high-quality, affordable treatment products or services in line with national health system priorities.
We have distributed over 3 million pre-packaged treatments for pneumonia, preventing more than 230,000 DALYs. In 2013, our TB programs prevented 153,500 DALYs in 13 countries.
Our integrated case management programs reduce death and severe disease due to malaria, pneumonia, diarrhea, and severe acute malnutrition, with prompt and effective diagnosis and treatment where and when people need it. We are focused on improving access to effective treatment, enhancing quality of care, and increasing informed demand among caregivers to seek prompt and effective treatment from trained providers.
- Pneumonia: We focus on integrated case management and pre-packaged treatment to ensure access to appropriate and affordable care.
- Tuberculosis: We leverage our expertise in private-sector engagement, service integration and behavior change communications to increase access to quality TB care for poor and vulnerable populations.
- Non-Communicable Disease Life Course Pocket Cards
At the 61st session of the UN"s Commission on the Status of Women, PSI and its partners on the Women and NCDs Task Force promoted a set of pocket cards illustrating a woman's risk for non-communicable diseases over the course of her lifetime.
- The Effectiveness of Social Marketing in Global Health: a Systematic Review
Social marketing is a commonly used strategy in global health. Social marketing programmes may sell subsidized products through commercial sector outlets, distribute appropriately priced products, deliver health services through social franchises and promote behaviours not dependent upon a product or service. The document aims to review evidence of the effectiveness of social marketing in low- and middle-income countries, focusing on major areas of investment in global health: HIV, reproductive health, child survival, malaria and tuberculosis.
- Barriers to Provider Initiated HIV Testing and Counseling (PITC) Among TB Patients in Myanmar
In Myanmar, we introduced provider-initiated testing and counseling (PITC) to increase the detection of HIV among TB patients. As part of this work, we conducted research to identify barriers to PITC-uptake among TB patients
- Comparison of Different Models for Active TB Case Finding in Zimbabwe
We recently evaluated our efforts to increase TB case detection among people living with HIV in Zimbabwe using routine data collected during service delivery. The evaluation found that offering TB screening and diagnosis services as part of the delivery of HTC services was more effective than broader community outreach efforts
- TB Case Detection via Private Pharmacies in Lao PDR
In Laos, we use a tailored incentive scheme to increase case detection among pharmacists in the private sector.
- Engagement of Non-Allopathic/AYUSH Health Care Providers in TB Care and Control: Results of Two Years of Implementation
In India, many people seek care from practitioners of alternative medicine. We sensitize these providers about TB, training them to detect the symptoms of TB and to link clients to laboratory diagnostics available free of charge in the public sector. This ensures that patients with TB are diagnosed as quickly as possible and linked to quality TB treatment. As many as 29 percent of all patients referred by these providers tested positive for TB.
- Private Sector Healthcare Myanmar: Evidence from the ‘Sun’ Social Franchise
As an evidence-based model, social franchising puts high quality healthcare within the reach of people in need around the world. This report showcases results from four studies led by researchers from PSI, the University of California, San Francisco (UCSF), and Johns Hopkins University, which demonstrate how social franchising networks, like PSI/Myanmar's Sun Quality Network, improve the quality of health service delivery and health outcomes at-scale, cost effectively and equitably.
- Follow the Need: Recipe for Scaling Up Access to Quality Pneumonia, Diarrhea and Malaria Case Management in South Sudan
Looking at certain 'ingredients,' this case study outlines how PSI and partners are working to scale up access to, quality of, and demand for improved health services and products in South Sudan using integrated community case management (iCCM). It also delineates keys to success and lessons learned from the study.
- DALY Brief: Calculation for Pneumonia Pre-Packaged Treatment (PPT)
This brief presents a guide to calculating DALYs for pneumonia pre-packaged treatment (PPT).
- Technical Program Guide: Pneumonia
This brief provides a technical guide to pneumonia. It delineates the global framework to control the disease, the challenges in regards to quality, access and demand, PSI's strategic response and more.